How is the safety of vaccines established?
The safety of vaccines is paramount before they come anywhere near a healthy person, and there are many different players involved in establishing and monitoring this process: researchers, public health institutions, industry and others all play a role. This panel discussion brings together people involved in different aspects of vaccine safety. They will discuss the complex processes, licensing and monitoring that goes on behind the scenes and which has been the subject of many questions from the public-rightly or wrongly?
Deborah Cohen - BBC
- Dr Ian Feavers - The Medicines and Healthcare products Regulatory Agency, MHRA (UK)
- Stephen Lockhart - Vice President, Vaccine Clinical R&D Europe and Asia-Pacific Head at Pfizer
- Professor David Heymann - Professor of Infectious Disease Epidemiology, LSHTM, head of Centre on Global Health Security at Chatham House
Fahmida Yesmin - Mosaic Community Trust, London